[非小细胞肺癌局部热消融的进展与挑战]
[Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer].
作者信息
Gou Qing, Zhou Zejian, Zhao Mingfang, Chen Xiaoming, Zhou Qing
机构信息
Department of Interventional Oncology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou 510080, China.
The First Hospital of China Medical University, Department of Medical Oncology, Shenyang 110001, China.
出版信息
Zhongguo Fei Ai Za Zhi. 2020 Feb 20;23(2):111-117. doi: 10.3779/j.issn.1009-3419.2020.02.06.
Abstract
Non-small cell lung cancer (NSCLC) is the most common pathological type of primary lung cancer. Currently, main treatment approaches for NSCLC patients include surgical resection, radiotherapy, chemotherapy, targeted therapy and so on. In recent years, thermal ablation has received increasing attention in the treatment of various stages of NSCLC. As a safe and efficient local treatment, thermal ablation may bring potential clinical benefits to NSCLC patients. However, many issues remain unsolved and further investigation is needed in the clinical application of thermal ablation in NSCLC. In this review, we aim to summarize the applications of thermal ablation in NSCLC and further discuss the emerging controversies as well as future research directions.
摘要
非小细胞肺癌（NSCLC）是原发性肺癌最常见的病理类型。目前，NSCLC患者的主要治疗方法包括手术切除、放疗、化疗、靶向治疗等。近年来，热消融在NSCLC各阶段治疗中受到越来越多的关注。作为一种安全有效的局部治疗方法，热消融可能给NSCLC患者带来潜在的临床益处。然而，许多问题仍未解决，热消融在NSCLC临床应用中仍需进一步研究。在本综述中，我们旨在总结热消融在NSCLC中的应用，并进一步讨论新出现的争议以及未来的研究方向。
相似文献
1
[Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer].[非小细胞肺癌局部热消融的进展与挑战]
Zhongguo Fei Ai Za Zhi. 2020 Feb 20;23(2):111-117. doi: 10.3779/j.issn.1009-3419.2020.02.06.
2
Percutaneous CT-guided thermal ablation as salvage therapy for recurrent non-small cell lung cancer after external beam radiotherapy: A retrospective study.经皮CT引导下热消融作为非小细胞肺癌外照射放疗后复发的挽救治疗：一项回顾性研究。
Int J Hyperthermia. 2016 May;32(3):316-23. doi: 10.3109/02656736.2015.1137640. Epub 2016 Feb 19.
3
Comparison of Survival Rates After a Combination of Local Treatment and Systemic Therapy vs Systemic Therapy Alone for Treatment of Stage IV Non-Small Cell Lung Cancer.局部治疗联合全身治疗与单纯全身治疗治疗 IV 期非小细胞肺癌的生存率比较。
JAMA Netw Open. 2019 Aug 2;2(8):e199702. doi: 10.1001/jamanetworkopen.2019.9702.
4
Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Ⅰ期和Ⅱ期非小细胞肺癌的治疗：肺癌的诊断和管理，第 3 版：美国胸科医师学会循证临床实践指南。
Chest. 2013 May;143(5 Suppl):e278S-e313S. doi: 10.1378/chest.12-2359.
5
Percutaneous thermal ablation of lung tumors - Radiofrequency, microwave and cryotherapy: Where are we going?经皮肺肿瘤热消融治疗 - 射频、微波和冷冻治疗：我们的前路在何方？
Diagn Interv Imaging. 2017 Sep;98(9):619-625. doi: 10.1016/j.diii.2017.07.003. Epub 2017 Aug 24.
6
Percutaneous image-guided thermal ablation of lung cancer: What is the evidence?经皮影像引导下肺癌热消融术：证据有哪些？
Lung Cancer. 2023 Feb;176:14-23. doi: 10.1016/j.lungcan.2022.12.010. Epub 2022 Dec 22.
7
8
Update on Image-Guided Thermal Lung Ablation: Society Guidelines, Therapeutic Alternatives, and Postablation Imaging Findings.影像引导下热消融治疗肺部疾病的最新进展：学会指南、治疗选择及消融后影像学表现。
AJR Am J Roentgenol. 2022 Sep;219(3):471-485. doi: 10.2214/AJR.21.27099. Epub 2022 Mar 23.
9
Novel treatment options in stage I non-small-cell lung cancer.I期非小细胞肺癌的新型治疗选择
Expert Rev Anticancer Ther. 2014 Sep;14(9):1007-20. doi: 10.1586/14737140.2014.929500. Epub 2014 Jun 14.
10
[Non-Small Cell Lung Cancer - from Immunobiology to Immunotherapy].[非小细胞肺癌——从免疫生物学到免疫治疗]
Klin Onkol. 2016 Fall;29 Suppl 4(Suppl 4):78-87.
引用本文的文献
1
[Advances in the Treatment of Multiple Primary Lung Cancer].[多原发性肺癌的治疗进展]
Zhongguo Fei Ai Za Zhi. 2025 Jun 20;28(6):460-466. doi: 10.3779/j.issn.1009-3419.2025.102.17.
2
CT-guided Percutaneous Microwave Ablation Combined with Local Radiotherapy or Chemotherapy of Malignant Pulmonary Tumors.CT 引导下经皮微波消融联合局部放化疗治疗肺部恶性肿瘤。
Curr Radiopharm. 2024;17(2):184-199. doi: 10.2174/0118744710261655231214105406.
3
Clinical effect of cold and heat ablation on patients with advanced lung cancer and its influence on immune function.冷热消融对晚期肺癌患者的临床疗效及其对免疫功能的影响
Am J Transl Res. 2023 Apr 15;15(4):2939-2948. eCollection 2023.
4
Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors.高热联合免疫检查点抑制剂治疗原发性和转移性肿瘤。
Front Immunol. 2022 Aug 12;13:969447. doi: 10.3389/fimmu.2022.969447. eCollection 2022.
5
Review of Deep Learning Based Automatic Segmentation for Lung Cancer Radiotherapy.基于深度学习的肺癌放疗自动分割综述
Front Oncol. 2021 Jul 8;11:717039. doi: 10.3389/fonc.2021.717039. eCollection 2021.
本文引用的文献
1
Efficacy and safety of microwave ablation in the treatment of patients with oligometastatic non-small-cell lung cancer: a retrospective study.微波消融治疗寡转移非小细胞肺癌患者的疗效和安全性：一项回顾性研究。
Int J Hyperthermia. 2019;36(1):827-834. doi: 10.1080/02656736.2019.1642522.
2
Microwave ablation combined with chemotherapy improved progression free survival of IV stage lung adenocarcinoma patients compared with chemotherapy alone.微波消融联合化疗较单纯化疗改善 IV 期肺腺癌患者无进展生存期。
Thorac Cancer. 2019 Jul;10(7):1628-1635. doi: 10.1111/1759-7714.13129. Epub 2019 Jun 27.
3
Radiofrequency ablation of liver metastasis: potential impact on immune checkpoint inhibitor therapy.射频消融治疗肝转移瘤：对免疫检查点抑制剂治疗的潜在影响。
Eur Radiol. 2019 Sep;29(9):5045-5051. doi: 10.1007/s00330-019-06189-6. Epub 2019 Apr 8.
4
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
5
Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.Ⅰ期非小细胞肺癌行热消融与立体定向放疗的生存率比较：一项国家癌症数据库研究。
Radiology. 2018 Dec;289(3):862-870. doi: 10.1148/radiol.2018180979. Epub 2018 Sep 18.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.无法进行手术的IA期非小细胞肺癌患者的射频消融治疗：一项前瞻性多中心II期试验的结果
J Cardiothorac Surg. 2018 Aug 24;13(1):91. doi: 10.1186/s13019-018-0773-y.
8
Expert consensus workshop report: Guidelines for thermal ablation of primary and metastatic lung tumors (2018 edition).专家共识研讨会报告：原发性和转移性肺肿瘤热消融指南（2018年版）
J Cancer Res Ther. 2018;14(4):730-744. doi: 10.4103/jcrt.JCRT_221_18.
9
Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors.微波消融联合持续 EGFR 酪氨酸激酶抑制剂治疗延长 EGFR 酪氨酸激酶抑制剂获得性耐药的非小细胞肺癌患者的疾病控制时间。
Thorac Cancer. 2018 Aug;9(8):1012-1017. doi: 10.1111/1759-7714.12779. Epub 2018 Jun 20.
10
Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.使用 FDG PET/CT 引导下肝肿瘤消融时氨灌注 PET 进行术中消融边缘评估：一项初步研究。
Radiology. 2018 Jul;288(1):138-145. doi: 10.1148/radiol.2018172108. Epub 2018 Apr 3.
Zotero 插件